Consumption of soft drinks and juices and risk of liver and biliary tract cancers in a European cohort
详细信息 查看全文
- 作者：Magdalena Stepien ; Talita Duarte-Salles ; Veronika Fedirko…
- 关键词：Hepatocellular carcinoma ; Biliary tract cancers ; Soft drink ; Fruit and vegetable juice ; Prospective cohort
- 刊名：European Journal of Nutrition
- 出版年：2016
- 出版时间：February 2016
- 年：2016
- 卷：55
- 期：1
- 页码：7-20
- 全文大小：526 KB
- 参考文献：1.Bosman FT, Carneiro F, Hruban RH, Theise ND (2010) WHO classification of tumours of the digestive system, vol 3, 4th edn. IARC, Lyon
2.IARC (2012) Estimated incidence, mortality and 5-year prevalence. http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx . Accessed 27 Aug 2014
3.WHO (2014) Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/ . Accessed 27 Aug 2014
4.Chuang SC, La Vecchia C, Boffetta P (2009) Liver cancer: descriptive epidemiology and risk factors other than HBV and HCV infection. Cancer Lett 286(1):9–14. doi:10.1016/j.canlet.2008.10.040 CrossRef
5.Trichopoulos D, Bamia C, Lagiou P, Fedirko V, Trepo E, Jenab M, Pischon T, Nothlings U, Overved K, Tjonneland A, Outzen M, Clavel-Chapelon F, Kaaks R, Lukanova A, Boeing H, Aleksandrova K, Benetou V, Zylis D, Palli D, Pala V, Panico S, Tumino R, Sacerdote C, Bueno-De-Mesquita HB, Van Kranen HJ, Peeters PH, Lund E, Quiros JR, Gonzalez CA, Sanchez Perez MJ, Navarro C, Dorronsoro M, Barricarte A, Lindkvist B, Regner S, Werner M, Hallmans G, Khaw KT, Wareham N, Key T, Romieu I, Chuang SC, Murphy N, Boffetta P, Trichopoulou A, Riboli E (2011) Hepatocellular carcinoma risk factors and disease burden in a European cohort: a nested case-control study. J Natl Cancer Inst 103(22):1686–1695. doi:10.1093/jnci/djr395 CrossRef
6.Blonski W, Kotlyar DS, Forde KA (2010) Non-viral causes of hepatocellular carcinoma. World J Gastroenterol 16(29):3603–3615CrossRef
7.Gomaa AI, Khan SA, Toledano MB, Waked I, Taylor-Robinson SD (2008) Hepatocellular carcinoma: epidemiology, risk factors and pathogenesis. World J Gastroenterol 14(27):4300–4308CrossRef
8.Schlesinger S, Aleksandrova K, Pischon T, Jenab M, Fedirko V, Trepo E, Overvad K, Roswall N, Tjonneland A, Boutron-Ruault MC, Fagherazzi G, Racine A, Kaaks R, Grote VA, Boeing H, Trichopoulou A, Pantzalis M, Kritikou M, Mattiello A, Sieri S, Sacerdote C, Palli D, Tumino R, Peeters PH, Bueno-de-Mesquita HB, Weiderpass E, Quiros JR, Zamora-Ros R, Sanchez MJ, Arriola L, Ardanaz E, Tormo MJ, Nilsson P, Lindkvist B, Sund M, Rolandsson O, Khaw KT, Wareham N, Travis RC, Riboli E, Nothlings U (2013) Diabetes mellitus, insulin treatment, diabetes duration, and risk of biliary tract cancer and hepatocellular carcinoma in a European cohort. Ann Oncol 24(9):2449–2455. doi:10.1093/annonc/mdt204 CrossRef
9.Patel T (2002) Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2:10CrossRef
10.Ren HB, Yu T, Liu C, Li YQ (2011) Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes Control 22(6):837–847. doi:10.1007/s10552-011-9754-3 CrossRef
11.Fedirko V, Lukanova A, Bamia C, Trichopolou A, Trepo E, Nothlings U, Schlesinger S, Aleksandrova K, Boffetta P, Tjonneland A, Johnsen NF, Overvad K, Fagherazzi G, Racine A, Boutron-Ruault MC, Grote V, Kaaks R, Boeing H, Naska A, Adarakis G, Valanou E, Palli D, Sieri S, Tumino R, Vineis P, Panico S, Bueno-de-Mesquita HB, Siersema PD, Peeters PH, Weiderpass E, Skeie G, Engeset D, Quiros JR, Zamora-Ros R, Sanchez MJ, Amiano P, Huerta JM, Barricarte A, Johansen D, Lindkvist B, Sund M, Werner M, Crowe F, Khaw KT, Ferrari P, Romieu I, Chuang SC, Riboli E, Jenab M (2013) Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans. Ann Oncol 24(2):543–553. doi:10.1093/annonc/mds434 CrossRef
12.Montonen J, Jarvinen R, Knekt P, Heliovaara M, Reunanen A (2007) Consumption of sweetened beverages and intakes of fructose and glucose predict type 2 diabetes occurrence. J Nutr 137(6):1447–1454
13.Assy N, Nasser G, Kamayse I, Nseir W, Beniashvili Z, Djibre A, Grosovski M (2008) Soft drink consumption linked with fatty liver in the absence of traditional risk factors. Can J Gastroenterol 22(10):811–816
14.Abid A, Taha O, Nseir W, Farah R, Grosovski M, Assy N (2009) Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome. J Hepatol 51(5):918–924. doi:10.1016/j.jhep.2009.05.033 CrossRef
15.Malik VS, Popkin BM, Bray GA, Despres JP, Willett WC, Hu FB (2010) Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis. Diabetes Care 33(11):2477–2483. doi:10.2337/dc10-1079 CrossRef
16.Hu FB, Malik VS (2010) Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence. Physiol Behav 100(1):47–54. doi:10.1016/j.physbeh.2010.01.036 CrossRef
17.Nielsen SJPB (2004) Changes in beverage intake between 1977 and 2001. Am J Prev Med 27(3):205–210CrossRef
18.Schernhammer ES, Hu FB, Giovannucci E, Michaud DS, Colditz GA, Stampfer MJ, Fuchs CS (2005) Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 14(9):2098–2105. doi:10.1158/1055-9965.EPI-05-0059
19.Bao Y, Stolzenberg-Solomon R, Jiao L, Silverman DT, Subar AF, Park Y, Leitzmann MF, Hollenbeck A, Schatzkin A, Michaud DS (2008) Added sugar and sugar-sweetened foods and beverages and the risk of pancreatic cancer in the National Institutes of Health-AARP Diet and Health Study. Am J Clin Nutr 88(2):431–440
20.Genkinger JM, Li R, Spiegelman D, Anderson KE, Albanes D, Bergkvist L, Bernstein L, Black A, van den Brandt PA, English DR, Freudenheim JL, Fuchs CS, Giles GG, Giovannucci E, Goldbohm RA, Horn-Ross PL, Jacobs EJ, Koushik A, Mannisto S, Marshall JR, Miller AB, Patel AV, Robien K, Rohan TE, Schairer C, Stolzenberg-Solomon R, Wolk A, Ziegler RG, Smith-Warner SA (2012) Coffee, tea, and sugar-sweetened carbonated soft drink intake and pancreatic cancer risk: a pooled analysis of 14 cohort studies. Cancer epidemiology, biomarkers & prevention: a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 21(2):305–318. doi:10.1158/1055-9965.EPI-11-0945-T
21.Zhang X, Albanes D, Beeson WL, van den Brandt PA, Buring JE, Flood A, Freudenheim JL, Giovannucci EL, Goldbohm RA, Jaceldo-Siegl K, Jacobs EJ, Krogh V, Larsson SC, Marshall JR, McCullough ML, Miller AB, Robien K, Rohan TE, Schatzkin A, Sieri S, Spiegelman D, Virtamo J, Wolk A, Willett WC, Zhang SM, Smith-Warner SA (2010) Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst 102(11):771–783. doi:10.1093/jnci/djq107 CrossRef
22.Ren JS, Freedman ND, Kamangar F, Dawsey SM, Hollenbeck AR, Schatzkin A, Abnet CC (2010) Tea, coffee, carbonated soft drinks and upper gastrointestinal tract cancer risk in a large United States prospective cohort study. Eur J Cancer 46(10):1873–1881. doi:10.1016/j.ejca.2010.03.025 CrossRef
23.Lagergren J, Viklund P, Jansson C (2006) Carbonated soft drinks and risk of esophageal adenocarcinoma: a population-based case-control study. J Natl Cancer Inst 98(16):1158–1161. doi:10.1093/jnci/djj310 CrossRef
24.Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, Charrondiere UR, Hemon B, Casagrande C, Vignat J, Overvad K, Tjonneland A, Clavel-Chapelon F, Thiebaut A, Wahrendorf J, Boeing H, Trichopoulos D, Trichopoulou A, Vineis P, Palli D, Bueno-De-Mesquita HB, Peeters PH, Lund E, Engeset D, Gonzalez CA, Barricarte A, Berglund G, Hallmans G, Day NE, Key TJ, Kaaks R, Saracci R (2002) European prospective investigation into cancer and nutrition (EPIC): study populations and data collection. Public Health Nutr 5(6B):1113–1124. doi:10.1079/PHN2002394 CrossRef
25.Margetts BM, Pietinen P (1997) European prospective investigation into cancer and nutrition: validity studies on dietary assessment methods. Int J Epidemiol 26(Suppl 1):S1–S5CrossRef
26.Slimani N, Deharveng G, Unwin I, Southgate DA, Vignat J, Skeie G, Salvini S, Parpinel M, Moller A, Ireland J, Becker W, Farran A, Westenbrink S, Vasilopoulou E, Unwin J, Borgejordet A, Rohrmann S, Church S, Gnagnarella P, Casagrande C, van Bakel M, Niravong M, Boutron-Ruault MC, Stripp C, Tjonneland A, Trichopoulou A, Georga K, Nilsson S, Mattisson I, Ray J, Boeing H, Ocke M, Peeters PH, Jakszyn P, Amiano P, Engeset D, Lund E, de Magistris MS, Sacerdote C, Welch A, Bingham S, Subar AF, Riboli E (2007) The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 61(9):1037–1056. doi:10.1038/sj.ejcn.1602679 CrossRef
27.EFSA (2001) COUNCIL DIRECTIVE 2001/112/EC of 20 December 2001 relating to fruit juices and certain similar products intended for human consumption. Off J Eur Commun
28.Byrne T, Wilmore D (1998) Does growth hormone and glutamine enhance bowel absorption? Gastroenterology 114(5):1110–1112CrossRef
29.Willett WC, Howe GR, Kushi LH (1997) Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 65(4 Suppl):1220S–1228S (discussion 1229S–1231S)
30.Aragon G, Younossi ZM (2010) When and how to evaluate mildly elevated liver enzymes in apparently healthy patients. Clevel Clin J Med 77(3):195–204. doi:10.3949/ccjm.77a.09064 CrossRef
31.Ventura EE, Davis JN, Goran MI (2011) Sugar content of popular sweetened beverages based on objective laboratory analysis: focus on fructose content. Obesity (Silver Spring) 19(4):868–874. doi:10.1038/oby.2010.255 CrossRef
32.Densupsoontorn N, Jirapinyo P, Thamonsiri N, Wongarn R, Phosuya P, Tritiprat A, Patraarat S, Pidatcha P, Suwannthol L (2002) Comparison of the nutrient content of fresh fruit juices vs commercial fruit juices. J Med Assoc Thail 85(Suppl 2):S732–S738
33.Malik VS, Pan A, Willett WC, Hu FB (2013) Sugar-sweetened beverages and weight gain in children and adults: a systematic review and meta-analysis. Am J Clin Nutr 98(4):1084–1102. doi:10.3945/ajcn.113.058362 CrossRef
34.Hu FB (2013) Resolved: there is sufficient scientific evidence that decreasing sugar-sweetened beverage consumption will reduce the prevalence of obesity and obesity-related diseases. Obes Rev 14(8):606–619. doi:10.1111/obr.12040 CrossRef
35.Malik VS, Popkin BM, Bray GA, Despres JP, Hu FB (2010) Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk. Circulation 121(11):1356–1364. doi:10.1161/CIRCULATIONAHA.109.876185 CrossRef
36.Ludwig DS (2002) The glycemic index: physiological mechanisms relating to obesity, diabetes, and cardiovascular disease. JAMA 287(18):2414–2423CrossRef
37.Stanhope KL, Griffen SC, Bair BR, Swarbrick MM, Keim NL, Havel PJ (2008) Twenty-four-hour endocrine and metabolic profiles following consumption of high-fructose corn syrup-, sucrose-, fructose-, and glucose-sweetened beverages with meals. Am J Clin Nutr 87(5):1194–1203
38.Ouyang X, Cirillo P, Sautin Y, McCall S, Bruchette JL, Diehl AM, Johnson RJ, Abdelmalek MF (2008) Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 48(6):993–999. doi:10.1016/j.jhep.2008.02.011 CrossRef
39.Zelber-Sagi S, Nitzan-Kaluski D, Goldsmith R, Webb M, Blendis L, Halpern Z, Oren R (2007) Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 47(5):711–717. doi:10.1016/j.jhep.2007.06.020 CrossRef
40.Rafiq N. YZM (2008) The impact of non-alcoholic fatty liver disease on chronic hepatitis B and C. Pract Gastroenterol (July 2008) (Viral hepatitis, Series 7)
41.Romaguera D, Norat T, Wark PA, Vergnaud AC, Schulze MB, van Woudenbergh GJ, Drogan D, Amiano P, Molina-Montes E, Sanchez MJ, Balkau B, Barricarte A, Beulens JW, Clavel-Chapelon F, Crispim SP, Fagherazzi G, Franks PW, Grote VA, Huybrechts I, Key TJ, Khaw KT, Nilsson P, Overvad K, Palli D, Panico S, Quiros JR, Rolandsson O, Sacerdote C, Sieri S, Slimani N, Spijkerman AM, Tjonneland A, Tormo MJ, Tumino R, van den Berg SW, Wermeling PR, Zamara-Ros R, Feskens EJ, Langenberg C, Sharp SJ, Foroughi NG, Riboli E, Wareham NJ (2013) Consumption of sweet beverages and type 2 diabetes incidence in European adults: results from EPIC-InterAct. Diabetologia 56(7):1520–1530. doi:10.1007/s00125-013-2899-8 CrossRef
42.Suez J, Korem T, Zeevi D, Zilberman-Schapira G, Thaiss CA, Maza O, Israeli D, Zmora N, Gilad S, Weinberger A, Kuperman Y, Harmelin A, Kolodkin-Gal I, Shapiro H, Halpern Z, Segal E, Elinav E (2014) Artificial sweeteners induce glucose intolerance by altering the gut microbiota. Nature 514(7521):181–186. doi:10.1038/nature13793
43.Duffey KJ, Popkin BM (2006) Adults with healthier dietary patterns have healthier beverage patterns. J Nutr 136(11):2901–2907
44.Bazzano LA, Li TY, Joshipura KJ, Hu FB (2008) Intake of fruit, vegetables, and fruit juices and risk of diabetes in women. Diabetes Care 31(7):1311–1317. doi:10.2337/dc08-0080 CrossRef
45.Potter JD, Steinmetz K (1996) Vegetables, fruit and phytoestrogens as preventive agents. IARC Sci Publ 139:61–90
46.Stagos D, Amoutzias GD, Matakos A, Spyrou A, Tsatsakis AM, Kouretas D (2012) Chemoprevention of liver cancer by plant polyphenols. Food Chem Toxicol 50(6):2155–2170. doi:10.1016/j.fct.2012.04.002 CrossRef
47.Cust AE, Skilton MR, van Bakel MM, Halkjaer J, Olsen A, Agnoli C, Psaltopoulou T, Buurma E, Sonestedt E, Chirlaque MD, Rinaldi S, Tjonneland A, Jensen MK, Clavel-Chapelon F, Boutron-Ruault MC, Kaaks R, Nothlings U, Chloptsios Y, Zylis D, Mattiello A, Caini S, Ocke MC, van der Schouw YT, Skeie G, Parr CL, Molina-Montes E, Manjer J, Johansson I, McTaggart A, Key TJ, Bingham S, Riboli E, Slimani N (2009) Total dietary carbohydrate, sugar, starch and fibre intakes in the European Prospective Investigation into Cancer and Nutrition. Eur J Clin Nutr 63(Suppl 4):S37–S60. doi:10.1038/ejcn.2009.74 CrossRef - 作者单位：Magdalena Stepien (1)
Talita Duarte-Salles (1)
Veronika Fedirko (1) (2)
Antonia Trichopoulou (3) (4)
Pagona Lagiou (4) (5)
Christina Bamia (4)
Kim Overvad (6)
Anne Tjønneland (7)
Louise Hansen (7)
Marie-Christine Boutron-Ruault (10) (8) (9)
Guy Fagherazzi (10) (8) (9)
Gianluca Severi (11) (12)
Tilman Kühn (13)
Rudolf Kaaks (13)
Krasimira Aleksandrova (14)
Heiner Boeing (14)
Eleni Klinaki (3)
Domenico Palli (15)
Sara Grioni (16)
Salvatore Panico (17)
Rosario Tumino (18)
Alessio Naccarati (19)
H. Bas Bueno-de-Mesquita (20) (21) (22)
Petra H. Peeters (23)
Guri Skeie (24)
Elisabete Weiderpass (24) (25) (26) (27)
Christine L. Parr (28)
José Ramón Quirós (29)
Genevieve Buckland (30)
Esther Molina-Montes (31)
Pilar Amiano (32) (33)
Maria-Dolores Chirlaque (31) (33)
Eva Ardanaz (33) (34)
Emily Sonestedt (35)
Ulrika Ericson (36)
Maria Wennberg (37)
Lena Maria Nilsson (37)
Kay-Tee Khaw (38)
Nick Wareham (39)
Kathryn E. Bradbury (40)
Heather A. Ward (41)
Isabelle Romieu (1)
Mazda Jenab (1)
1. Section of Nutrition and Metabolism, International Agency for Research on Cancer (IARC-WHO), Lyon, France
2. Rollins School of Public Health, Winship Cancer Institute, Emory University, Atlanta, GA, USA
3. Hellenic Health Foundation, Athens, Greece
4. Department of Hygiene, Epidemiology, Medical Statistics, WHO Collaborating Center for Food and Nutrition Policies, University of Athens Medical School, Athens, Greece
5. Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
6. Section for Epidemiology, Department of Public Health, Aarhus University, Aarhus, Denmark
7. Danish Cancer Society Research Center, Copenhagen, Denmark
10. Institut Gustave Roussy, 94805, Villejuif, France
8. INSERM, Centre for Research in Epidemiology and Population Health (CESP), U1018, Nutrition, Hormones and Women’s Health Team, 94805, Villejuif, France
9. University Paris Sud, UMRS 1018, 94805, Villejuif, France
11. Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, 3053, Australia
12. Centre for Molecular, Environmental, Genetic, and Analytic Epidemiology, The University of Melbourne, Melbourne, 3010, Australia
13. Department of Cancer Epidemiology, German Cancer Research Centre, Heidelberg, Germany
14. Department of Epidemiology, German Institute of Human Nutrition, Potsdam-Rehbruecke, Nuthetal, Germany
15. Molecular and Nutritional Epidemiology Unit, Cancer Research and Prevention Institute – ISPO, Florence, Italy
16. Epidemiology and Prevention Unit, Fondazione IRCCS, Istituto Nazionale dei Tumori, Milan, Italy
17. Dipartamento di Medicina Clinicae Chirurgias, Federico II University, Naples, Italy
18. Cancer Registry and Histopathology Unit, “Civile M.P. Arezzo” Hospital, Ragusa, Italy
19. Molecular and Genetic Epidemiology Unit, Human Genetics Foundation (HuGeF), Torino, Italy
20. National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands
21. Department of Gastroenterology and Hepatology, University Medical Centre, Utrecht, The Netherlands
22. The School of Public Health, Imperial College London, London, UK
23. Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands
24. Department of Community Medicine, Faculty of Health Sciences, University of Tromso, The Arctic University of Norway, Tromsø, Norway
25. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
26. Department of Research, Cancer Registry of Norway, Oslo, Norway
27. Samfundet Folkhälsan, Helsinki, Finland
28. Division of Epidemiology, Norwegian Institute of Public Health, Oslo, Norway
29. Public Health Directorate, Asturias, Spain
30. Unit of Nutrition, Environment and Cancer, Cancer Epidemiology Research Programme, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain
31. Department of Epidemiology, Murcia Regional Health Authority, Murcia, Spain
32. Public Health Division of Gipuzkoa, Health Department of Basque Region, BioDonostia Research Institute, San Sebastian, Spain
33. CIBER Epidemiology and Public Health CIBERESP, Madrid, Spain
34. Navarre Public Health Institute, Pamplona, Spain
35. Department of Clinical Sciences – Malmö, Lund University, Malmö, Sweden
36. Diabetes and Cardiovascular Disease, Genetic Epidemiology, Department of Clinical Sciences in Malmö, Lund University, Malmö, Sweden
37. Public Health and Clinical Medicine, Nutritional Research, and Arctic Research Center, Umeå University, Umeå, Sweden
38. School of Clinical Medicine, Clinical Gerontology Unit, University of Cambridge, Cambridge, UK
39. MRC Epidemiology Unit, University of Cambridge, Cambridge, UK
40. Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK
41. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College, London, UK - 刊物类别：Chemistry and Materials Science
- 刊物主题：Chemistry
Nutrition - 出版者：Springer Berlin / Heidelberg
- ISSN：1436-6215
文摘
Purpose The aim of the study was to assess associations between intake of combined soft drinks (sugar sweetened and artificially sweetened) and fruit and vegetable juices and the risk of hepatocellular carcinoma (HCC), intrahepatic bile duct (IHBC) and biliary tract cancers (GBTC) using data from the European Prospective Investigation into Cancer and Nutrition cohort of 477,206 participants from 10 European countries.